Research Provides Benchmark for Distinguishing Natural Outbreaks from Laboratory Scenarios
Most pandemic viruses that have jumped from animals to humans do not show signs of special adaptations to infect people, with one notable exception: the 1977 influenza outbreak, which was likely "sparked by a laboratory strain", according to a groundbreaking new study published in the journal Cell. This research fundamentally challenges previous assumptions about how zoonotic viruses evolve and spread, offering crucial insights into the origins of pandemics.
Upending Long-Held Assumptions About Viral Evolution
Until now, scientists have generally assumed that viruses jumping from wildlife to humans first acquire specific mutations that enable sustained human-to-human transmission. However, the new research reveals that most viruses were already "pre-adapted" for humans before their outbreaks began. Measurable changes in virus genomes typically appear only after they spill over to humans and begin sustained transmission within human populations.
"This work has direct relevance to the ongoing controversy around Covid-19 origins," said study author Joel Wertheim, an evolutionary biologist from the University of California, San Diego School of Medicine. "From an evolutionary perspective, we find no evidence that SARS-CoV-2 was shaped by selection in a laboratory or prolonged evolution in an intermediate host prior to its emergence."
Analyzing Pandemic Viruses Across Decades
In their comprehensive study, researchers analyzed viral genomes from multiple major outbreaks, including those caused by influenza A virus, Ebola virus, Marburg virus, mpox virus, SARS-CoV, and the SARS-CoV-2 virus responsible for the COVID-19 pandemic. They specifically examined virus genomes from the evolutionary period immediately preceding human outbreaks, where any substantial adaptation before jumping to humans would likely leave a detectable imprint.
Scientists found no evolutionary signal in the genomes of most viruses suggesting they were being "pre-adapted" for humans before outbreaks occurred. "Rather than requiring rare, finely tuned adaptations in animals, many viruses may already possess the basic capacity to infect and transmit between humans," Dr. Wertheim explained.
The 1977 Russian Flu: A Clear Laboratory Origin
However, researchers identified "one historical outlier" that stands in stark contrast to all other pandemic viruses studied. Unlike other pathogens, the 1977 H1N1 influenza, commonly known as the "Russian flu," reemerged almost unchanged after a 20-year absence, a pattern that scientists say is difficult to reconcile with natural evolution.
The viral outbreak was first reported by the Soviet Union in 1977 and lasted until 1979. Researchers found that the 1977 H1N1 strain showed a clear evolutionary shift consistent with viruses that propagated in cell culture or laboratory animals. "Our results provide new molecular evidence supporting the long-suspected idea that the H1N1 pandemic was sparked by a laboratory strain – possibly in the context of a failed vaccine trial," Dr. Wertheim stated.
Implications for COVID-19 Origins and Future Preparedness
The absence of laboratory adaptation evidence in SARS-CoV-2 strongly indicates that the COVID-19 pandemic originated from a natural zoonotic event. "It represents another nail in the coffin for theories invoking laboratory manipulation," Dr. Wertheim emphasized regarding COVID-19 origins.
This research provides a valuable benchmark for distinguishing natural outbreaks from scenarios involving laboratory handling of pathogens. "If a virus had been extensively passaged in a lab before an outbreak, we would expect to see it in the evolutionary record. In nearly all pandemics we've studied, that signal simply isn't there," Dr. Wertheim noted.
The study's findings have significant implications for future pandemic preparedness and understanding of viral emergence. "Our goal is not just to understand the past, but to be better prepared for the future," the evolutionary biologist concluded, highlighting how this research can inform surveillance and response strategies for emerging infectious diseases worldwide.
